Geoffrey Johnson, MD, Ph.D., is a radiologist specializing in nuclear medicine at the Mayo Clinic in Rochester, Minnesota. Here, he discusses PET/CT scans and new "theranostics" treatments for prostate cancer, including the newly approved "Pluvicto" (lutetium-177). Theranostics is a combination of "therapy" and "diagnostics". It refers to the fact that the same radiotracer used for the PET scan ("PSMA" in the case of Pluvicto) is used to guide injectible radioactive particles to the sites of disease. View Dr. Johnson's faculty page here: mayoclinic.org/biographies/johnson-geoffrey-b-m-d-ph-d/bio-20055408
Get the full conference experience here: pcri.org/2022-conference
Watch Day 1 of the 2022 September Conference here: youtu.be/8Vdet74V-j8
Day 1 features the following lectures & Q&A sessions:
"PSMA PET, Theranostics, SPECT, and the Road Ahead in Prostate Cancer" by Geoffrey Johnson, MD, Ph.D
"Improving Quality of Life: ED, Incontinence, and More" by Jeffrey Brady, MD, FACS
"Active Surveillance Update 2022" by Laurence Klotz, CM, MD
Watch Day 2 of the 2022 September Conference here: youtu.be/8ToGNIyTNB0
Day 2 features the following lectures and Q&A sessions:
"2022 Hot Topics in Advanced Prostate Cancer" by Evan Yu, MD
"DIY Combat Manual for Beating Prostate Cancer" by Eugene Kwon, MD
"Conference Wrap Up" with Mark Moyad, MD, MPH, and Mark Scholz, MD
Don’t know your stage? Take the quiz: Visit prostatecancerstaging.org
To learn more about prostate cancer visit pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #GeoffreyJohnsonMD #PCRI
- PSMA Scans & Pluvicto (lutetium-177) in 2022 | Geoffrey Johnson, MD, PhD | PCRI Conference 2022 ( Download)
- PSMA & Lutetium-177 in 2022 | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer Part 4 ( Download)
- New FDA Approved: Pluvicto (Lutetium-177) for Advanced Prostate Cancer | Mark Scholz, MD | PCRI ( Download)
- Lu-PSMA Radioligand Therapy ( Download)
- Appropriate Use of PSMA PET in Clinical Practice ( Download)
- Appropriate Use of PSMA PET in Clinical Practice ( Download)
- 177 Lu PSMA Treatment for Prostate Cancer (Update: FDA approved on 3/23/22) ( Download)
- Treatment, Imaging, & More | Q+A with Eugene Kwon, MD & Mark Moyad, MD | 2021 PCRI Conference ( Download)
- Day 2 | Advanced Treatments, LU-177, Extended Q+A | 2022 Prostate Cancer Patient Conference ( Download)
- Treatments for Advanced Prostate Cancer in 2022 | Evan Yu, MD | PCRI ( Download)
- How to Integrate PSMA PET Findings Into Treatment Algorithms ( Download)
- 2021: PSMA and Prostate Imaging | Dr. Thomas Hope | 2021 Moyad + Scholz Mid-Year Update | PCRI ( Download)
- Remaining questions on PSMA PET imaging in prostate cancer ( Download)
- PSMA-PET scanning and management of cN1 prostate cancer ( Download)
- Does Sugar Feed Prostate Cancer Does Fatty/Adipose Tissue Attract Cancer | Mark Moyad, MD, MPH ( Download)
